In CRC mouse models, incomplete radiofrequency ablation(iRFA) induces sustained infiltration of MDSCs in residual tumors through tumor cell-derived CCL2, which inhibits T-cell function and hinders the efficacy of anti-PD-1 therapy. This evidence concerns the gene CCL2 and neoplasm.